Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut Hormones in Addiction
NCT02690987Phase 1Unknown
- Sponsor
- Imperial College London
- Start
- Aug 2015
- Primary completion
- Aug 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of exenatide and unacylated ghrelin in obesity, nicotine dependence and alcohol dependence (3 arms), sponsored by Imperial College London. Primary endpoint: Functional MRI measure of brain activation during cigarette, alcohol and food picture evaluation task at 4 years. Status: unknown.
02
Drugs
exenatideunacylated ghrelin
03
Conditions
obesitynicotine dependencealcohol dependence
Beyond the preview
Go deeper on NCT02690987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02690987.